Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis: A Case Report

Keigo Kobayashi; Ichiro Nakachi; Akifumi Mitsuishi; Daisuke Arai; Kaori Sakurai; Katsunori Masaki; Atsushi Chiyotani; Hidenori Takahashi; Toshiyuki Tahara; Kenzo Soejima

doi:10.1016/j.cllc.2019.02.004

Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis: A Case Report

Keigo Kobayashi, Ichiro Nakachi, Akifumi Mitsuishi, Daisuke Arai, Kaori Sakurai, Katsunori Masaki, Atsushi Chiyotani, Hidenori Takahashi, Toshiyuki Tahara, Kenzo Soejima

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	e30-e32
Journal	Clinical Lung Cancer
Volume	21
Issue number	1
DOIs	https://doi.org/10.1016/j.cllc.2019.02.004
Publication status	Published - 2020 Jan

Keywords

Immune-related adverse events
Immunotherapy
NSCLC
PD-1 inhibitors
Severe hepatitis

ASJC Scopus subject areas

Oncology
Pulmonary and Respiratory Medicine
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cllc.2019.02.004

Cite this

@article{ee2f6e66364d4a50bdf79ddf868d0762,

title = "Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis: A Case Report",

keywords = "Immune-related adverse events, Immunotherapy, NSCLC, PD-1 inhibitors, Severe hepatitis",

author = "Keigo Kobayashi and Ichiro Nakachi and Akifumi Mitsuishi and Daisuke Arai and Kaori Sakurai and Katsunori Masaki and Atsushi Chiyotani and Hidenori Takahashi and Toshiyuki Tahara and Kenzo Soejima",

year = "2020",

month = jan,

doi = "10.1016/j.cllc.2019.02.004",

language = "English",

volume = "21",

pages = "e30--e32",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis

T2 - A Case Report

AU - Kobayashi, Keigo

AU - Nakachi, Ichiro

AU - Mitsuishi, Akifumi

AU - Arai, Daisuke

AU - Sakurai, Kaori

AU - Masaki, Katsunori

AU - Chiyotani, Atsushi

AU - Takahashi, Hidenori

AU - Tahara, Toshiyuki

AU - Soejima, Kenzo

PY - 2020/1

Y1 - 2020/1

KW - Immune-related adverse events

KW - Immunotherapy

KW - NSCLC

KW - PD-1 inhibitors

KW - Severe hepatitis

UR - http://www.scopus.com/inward/record.url?scp=85074683829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074683829&partnerID=8YFLogxK

U2 - 10.1016/j.cllc.2019.02.004

DO - 10.1016/j.cllc.2019.02.004

M3 - Article

C2 - 31699508

AN - SCOPUS:85074683829

SN - 1525-7304

VL - 21

SP - e30-e32

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

IS - 1

ER -

Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis: A Case Report

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this